Hydroxyzine Pamoate
Product Images NDC 70934-444

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 70934-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 444 30 Master Bottle Label Approval Rev A 09 19)

Label (70934 444 30 Master Bottle Label Approval Rev A 09 19)
Hydroxyzine Pamoate Capsules, USP 25mg label for 30 capsules from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label shows the NDC 70934-444-30, dosage strength, quantity, and storage instructions to keep below 30°C (86°F). It indicates Rx-only status and is tartrazine dye-free, with warnings to keep out of children's reach.*
FDA Label Image

1 (Hydroxyzine Pamoate Capsules 1)

1 (Hydroxyzine Pamoate Capsules 1)
Chemical structure of Hydroxyzine Pamoate shown as two distinct molecular components, featuring a diphenylmethylpiperazine moiety and a pamoic acid moiety, including phenyl rings, hydroxyl, carboxyl, chlorine, and ether functional groups as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.